Study ﬁnds Ayurvedic supplement eﬀective for bedwetting children
Click here to read the original article.
In a clinical study with potty-trained children who still wet the bed, Urox showed statistically signiﬁcant improvement for occasional bedwetting.
Nocturnal enuresis or ‘bedwetting’ is a form of nighttime urinary incontinence occurring in younger children. Researchers point to several causes, from reduced bladder capacity, and/or an overactive bladder to genetics and even obstructive sleep apnea.
According to the National Sleep Foundation, 10% of children wet the bed. In an eﬀort to help stop children from extended bedwetting and assist families through a successful potty-training period, Seipel Group took their Urox formulation and created a dose for children. The children’s version, called Bedtime Buddy, was the subject of a study recently published Phytomedicine. This year, Urox won NutraIngredients' Botanical of The Year award.
The randomized double-blind placebo-controlled trial evaluated the eﬃcacy of Urox (Bedtime Buddy) against placebo for the treatment of nocturnal enuresis in children aged 6–14 years old over an eight week period. Forty one children completed the trial with an attrition rate of 16%. There were more males (64%) compared to females (35%) and the mean age was 8.6 years.
The participants were randomized via computerised random-number generation at study enrollment to receive one or two oral capsules in the morning of either Urox (Bedtime Buddy) or placebo. Each capsule contains 420 mg of a proprietary blend of Cratevox (Crataeva nurvala L.; Capparidaceae; Varuna) stem bark extract standardized for 1.5% lupeol: non-standardized Equisetum arvense L. (Equisetaceae; Horsetail) stem